Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 167.13M | $ 131.31M | $ 196.25M | $ 277.13M | $ 186.42M |
| Gross Profit | $ 156.06M | $ 96.27M | $ 143.42M | $ 214.96M | $ 156.00M |
| Operating Income | $ -22.61M | $ 11.94M | $ -25.50M | $ 78.89M | $ 8.55M |
| EBITDA | $ 40.79M | $ 101.73M | $ 54.41M | $ 133.16M | $ 69.05M |
| Net Income | $ -4.03M | $ 52.15M | $ -5.22M | $ 57.14M | $ -2.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 256.17M | $ 170.31M | $ 211.87M | $ 341.11M | $ 411.19M |
| Total Assets | $ 941.77M | $ 787.22M | $ 762.67M | $ 1.30B | $ 1.36B |
| Total Debt | $ 7.11M | $ 6.17M | $ 87.75M | $ 336.26M | $ 454.53M |
| Net Debt | $ -65.20M | $ -16.79M | $ 87.70M | $ 316.74M | $ 406.91M |
| Total Liabilities | $ 111.33M | $ 86.30M | $ 165.18M | $ 479.75M | $ 652.76M |
| Stockholders' Equity | $ 830.44M | $ 700.91M | $ 597.49M | $ 821.63M | $ 709.52M |
| Cash Flow | |||||
| Free Cash Flow | $ 95.23M | $ -4.27M | $ 119.93M | $ 70.04M | $ 50.13M |
| Operating Cash Flow | $ 97.05M | $ 49.58M | $ 137.85M | $ 78.80M | $ 54.59M |
| Investing Cash Flow | $ -143.66M | $ -11.68M | $ 163.62M | $ 30.52M | $ 231.65M |
| Financing Cash Flow | $ 97.14M | $ -59.95M | $ -275.99M | $ -137.76M | $ -310.55M |